Aug 9, 2021 PharmaCyte Biotech Announces Uplist Date to NASDAQ and Pricing of $15 Million Public Offering
Aug 2, 2021 PharmaCyte Biotech Announces Uplist to The Nasdaq Capital Market and Launch of Public Offering